Supported by

Left main and multivessel disease

Find all the latest content on left main and multivessel disease published on this website.

The left main coronary artery provides the primary source of blood flow to the left ventricle. Diseases affecting the left main, by itself or in combination with multivessel disease, place the patient at significant risk for life-threatening cardiovascular events. Treatment requires an understanding of all available tools, devices and techniques, like those employed in invasive imaging and functional assessment, as well as taking into account underlying comorbidities such as diabetes. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks. Use the filters below to access PCRonline resources.

Filtered By
Left main and multivessel disease

422 results

A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study

24 Oct 2022

The purpose of the ROLEX Registry (Revascularization Of LEft main with resolute onyX) was to explore outcomes using a more contemporary drug eluting stent platform which is more suitable for LM PCI.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study

Porcelain aorta, calcified aortic valve, and calcified left main: what comes first, the valve or the artery?

08 Nov 2022

How would you treat this 76-year-old male patient with severe AS symptomatic for angina, sinus rhythm with RBBB, previous bilateral CEA, and total occlusion of both the left CCA and the subclavian?

Author

Flavio Luciano Ribichini
Petros Dardas

Author

Petros Dardas
Beatriz Vaquerizo

Author

Beatriz Vaquerizo
Porcelain aorta, calcified aortic valve, and calcified left main: what comes first, the valve or the artery?

DCB in variable day-to-day clinical scenarios

07 Oct 2022 – From AICT-AsiaPCR 2022

In this AICT AsiaPCR 2022 session 4 cases will be discussed that will enable you to learn more about drug-coated balloons and the variable indications for their use in daily practice, or techniques for using them in different lesion settings.

DCB in variable day-to-day clinical scenarios

Clinical cases - Coronary interventions - Session 4

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 5

07 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 8

07 Oct 2022 – From AICT-AsiaPCR 2022

Abstracts - Coronary interventions - Session 3

07 Oct 2022 – From AICT-AsiaPCR 2022

Advances in left main bifurcation PCI and renal denervation

06 Oct 2022 – From AICT-ASIAPCR 2022

Discover more about treatment strategies and recent evidence for left main bifurcation, the latest Malaysian Working Group consensus statement on renal denervation, as well as reviewing patient-centred clinical judgement and individualised treatment plans.

Advances in left main bifurcation PCI and renal denervation

Evolving approaches to planning and guiding of complex PCI with ultra-low contrast

06 Oct 2022 – From AICT-ASIAPCR 2022

In this session, presenters describe how to use IVUS and physiology in the assessment of left anterior descending and/or left circumflex ostium in distal left main disease. Discover in the second part the general principles and clinically validated strategies for ultralow contrast coronary angiography and zero...

Evolving approaches to planning and guiding of complex PCI with ultra-low contrast

Left main - DK crush stenting: LIVE case from National University Heart Centre - Singapore

06 Oct 2022 – From AICT-AsiaPCR 2022